Bortezomib, free base, 100mg

Bortezomib, free base, 100mg 

To Order Contact us: lieven@wlsolutions.be

Bortezomib

GP0262-5MG 5 mg
EUR 112.8

Bortezomib

T2399-10mg 10mg Ask for price
Description: Bortezomib

Bortezomib

T2399-1g 1g Ask for price
Description: Bortezomib

Bortezomib

T2399-1mg 1mg Ask for price
Description: Bortezomib

Bortezomib

T2399-50mg 50mg Ask for price
Description: Bortezomib

Bortezomib

T2399-5mg 5mg Ask for price
Description: Bortezomib

Bortezomib

100100 100.0mg
EUR 90

Bortezomib

GP0262-25 25
EUR 216.3

Bortezomib

GP0262-5 5
EUR 98.4

Bortezomib, 99%

BC010-005 5mg Ask for price

Bortezomib, 99%

BC010-010 10mg
EUR 213.6

Bortezomib, 99%

BC010-025 25mg
EUR 264

Bortezomib, 99%

BC010-050 50mg
EUR 327.6

Bortezomib, 99%

BC010-500 500mg
EUR 724.8

(1S,2S)-Bortezomib

T10061-10mg 10mg Ask for price
Description: (1S,2S)-Bortezomib

(1S,2S)-Bortezomib

T10061-1g 1g Ask for price
Description: (1S,2S)-Bortezomib

(1S,2S)-Bortezomib

T10061-1mg 1mg Ask for price
Description: (1S,2S)-Bortezomib

(1S,2S)-Bortezomib

T10061-50mg 50mg Ask for price
Description: (1S,2S)-Bortezomib

(1S,2S)-Bortezomib

T10061-5mg 5mg Ask for price
Description: (1S,2S)-Bortezomib

Bortezomib (PS-341)

A2614-10 10 mg
EUR 142.8
Description: Bortezomib (originally codenamed PS-341) is the first therapeutic proteasome inhibitor to the tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.

Bortezomib (PS-341)

A2614-100 100 mg
EUR 408
Description: Bortezomib (originally codenamed PS-341) is the first therapeutic proteasome inhibitor to the tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.

Bortezomib (PS-341)

A2614-25 25 mg
EUR 208.8
Description: Bortezomib (originally codenamed PS-341) is the first therapeutic proteasome inhibitor to the tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.

Bortezomib (PS-341)

A2614-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Bortezomib (originally codenamed PS-341) is the first therapeutic proteasome inhibitor to the tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.

Bortezomib (PS-341)

A2614-500 500 mg
EUR 1005.6
Description: Bortezomib (originally codenamed PS-341) is the first therapeutic proteasome inhibitor to the tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.

Bortezomib (PS-341)

A2614-S Evaluation Sample
EUR 97.2
Description: Bortezomib (originally codenamed PS-341) is the first therapeutic proteasome inhibitor to the tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.

Bortezomib-pinanediol

T7854-10mg 10mg Ask for price
Description: Bortezomib-pinanediol

Bortezomib-pinanediol

T7854-1g 1g Ask for price
Description: Bortezomib-pinanediol

Bortezomib-pinanediol

T7854-1mg 1mg Ask for price
Description: Bortezomib-pinanediol

Bortezomib-pinanediol

T7854-50mg 50mg Ask for price
Description: Bortezomib-pinanediol

Bortezomib-pinanediol

T7854-5mg 5mg Ask for price
Description: Bortezomib-pinanediol

Bortezomib-pinanediol

565251 5.0mg
EUR 265

Bortezomib (BTZ) Protein (BSA)

20-abx651876
  • EUR 693.60
  • EUR 309.60
  • EUR 2064.00
  • EUR 828.00
  • EUR 510.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Bortezomib (BTZ) Protein (OVA)

20-abx651877
  • EUR 693.60
  • EUR 309.60
  • EUR 2064.00
  • EUR 828.00
  • EUR 510.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

BSA Conjugated Bortezomib (BTZ)

4-CPK684Ge11
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Pan-species Bortezomib expressed in: E.coli

OVA Conjugated Bortezomib (BTZ)

4-CPK684Ge21
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Pan-species Bortezomib expressed in: E.coli

BSA Conjugated Bortezomib (BTZ)

RPU55087-100ug 100ug
EUR 431.2

BSA Conjugated Bortezomib (BTZ)

RPU55087-1mg 1mg
EUR 1911

BSA Conjugated Bortezomib (BTZ)

RPU55087-50ug 50ug
EUR 336

OVA Conjugated Bortezomib (BTZ)

RPU55088-100ug 100ug
EUR 431.2

OVA Conjugated Bortezomib (BTZ)

RPU55088-1mg 1mg
EUR 1911

OVA Conjugated Bortezomib (BTZ)

RPU55088-50ug 50ug
EUR 336

Bortezomib (Proteasome inhibitor)

SIH-328-25MG 25 mg
EUR 192
Description: The substance Bortezomib is a proteasome inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white powder which is soluble in 50 mg/ml DMSO, 35 mg/ml Ethanol.

Bortezomib (Proteasome inhibitor)

SIH-328-5MG 5 mg
EUR 138
Description: The substance Bortezomib is a proteasome inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white powder which is soluble in 50 mg/ml DMSO, 35 mg/ml Ethanol.

KRIBIOLISA Bortezomib (VELCADE) ELISA

KOD1013 1 x 96 wells
EUR 1067

M2698 free base

407496 200.0mg
EUR 2950

Biotin-X, free acid:100mg

90053 100MG
EUR 158.4
Description: Minimum order quantity: 1 unit of 100MG

Bioin-XX, free acid: (100mg)

90054 100MG
EUR 258
Description: Minimum order quantity: 1 unit of 100MG

I-37 free base( 2359690-13-2(free base))

T8721L-10mg 10mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))

T8721L-1g 1g Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))

T8721L-1mg 1mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))

T8721L-50mg 50mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))

T8721L-5mg 5mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

TMB free base

TB0954 1g
EUR 85.06

FIPI (free base)

B2372-25 each
EUR 757.2

FIPI (free base)

B2372-5 each
EUR 235.2

THZ1 (Free base)

9664-25 each
EUR 1227.6

THZ1 (Free base)

9664-5 each
EUR 352.8

R406 (free base)

A5880-100 100 mg
EUR 1452
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-25 25 mg
EUR 616.8
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5 5 mg
EUR 199.2
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5.1 10 mM (in 1mL DMSO)
EUR 316.8
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-S Evaluation Sample
EUR 97.2
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406(free base)

E1KS1533 2mg
EUR 625.2

R406 (free base)

HY-11108 10mM/1mL
EUR 277.2

R406 free base

T2467-10mg 10mg Ask for price
Description: R406 free base

R406 free base

T2467-1g 1g Ask for price
Description: R406 free base

R406 free base

T2467-1mg 1mg Ask for price
Description: R406 free base

R406 free base

T2467-50mg 50mg Ask for price
Description: R406 free base

R406 free base

T2467-5mg 5mg Ask for price
Description: R406 free base

SIS3 free base

T12923-10mg 10mg Ask for price
Description: SIS3 free base

SIS3 free base

T12923-1g 1g Ask for price
Description: SIS3 free base

SIS3 free base

T12923-1mg 1mg Ask for price
Description: SIS3 free base

SIS3 free base

T12923-50mg 50mg Ask for price
Description: SIS3 free base

SIS3 free base

T12923-5mg 5mg Ask for price
Description: SIS3 free base

FIPI free base

407955 200.0mg
EUR 1050

K201 free base

414202 5.0mg
EUR 288

S107 free base

530577 100.0mg
EUR 750

NG25 free base

562503 5.0mg
EUR 485

YM158 (free base)

HY-U00355 1mg
EUR 2770.8

YM158 free base

T10501-10mg 10mg Ask for price
Description: YM158 free base

YM158 free base

T10501-1g 1g Ask for price
Description: YM158 free base

YM158 free base

T10501-1mg 1mg Ask for price
Description: YM158 free base

Bortezomib, free base, 100mg